← Patent-cliff monitor small molecule ZEPOSIA OZANIMOD HYDROCHLORIDE
Loss of exclusivity September 2038 latest FDA-listed patent expiry
Company BRISTOL MYERS SQUIBB CO
Drug detail Brand name ZEPOSIA Active ingredient OZANIMOD HYDROCHLORIDE Strength EQ 0.23MG BASE Dosage form CAPSULE Route ORAL Modality Small molecule FDA approval March 2020 Marketing status RX
Listed patents Patent Expires Type 11680050 September 2038 substance, product 8481573 March 2033 substance, product 10239846 November 2030 use U-3740 9382217 May 2029 use U-2774 8796318 May 2029 substance, product
Regulatory exclusivity Code Expires M-309 August 2027
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.